NCT00003781View on ClinicalTrials.gov

Docetaxel in Treating Patients With Stage IV Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

December 31, 1998

Primary Completion Date

June 30, 2003

Study Completion Date

June 30, 2003

Conditions
PainProstate Cancer
Interventions
DRUG

docetaxel

PROCEDURE

pain therapy

PROCEDURE

quality-of-life assessment

Trial Locations (1)

97239

OHSU Knight Cancer Institute, Portland

All Listed Sponsors
lead

OHSU Knight Cancer Institute

OTHER

NCT00003781 - Docetaxel in Treating Patients With Stage IV Prostate Cancer | Biotech Hunter | Biotech Hunter